BioCentury | Aug 10, 2018
Company News

Astellas acquires ophthalmic company Quethera

...University of Cambridge. Quethera received undisclosed seed funding in 2015 from Cambridge Enterprise Ltd. and Midven's...
BioCentury | Sep 9, 2013
Financial News

Eagle Genomics completes venture financing

...Cambridge, U.K. Business: Bioinformatics Date completed: 9/2/13 Type: Venture financing Raised: £590,000 ($917,686) Investors: Midven...
BioCentury | Jan 31, 2011
Financial News

Microvisk completes venture financing

...Venture financing Raised: £6 million ($9.6 million) Investors: Porton Capital; Oxford Technology Management; New Hill; Midven...
BioCentury | Sep 20, 2010
Financial News

Microvisk completes venture financing

...Venture financing Raised: £2.5 million ($3.9 million) Investors: Oxford Technology Management; Porton Capital; New Hill; Midven...
Items per page:
1 - 4 of 4
BioCentury | Aug 10, 2018
Company News

Astellas acquires ophthalmic company Quethera

...University of Cambridge. Quethera received undisclosed seed funding in 2015 from Cambridge Enterprise Ltd. and Midven's...
BioCentury | Sep 9, 2013
Financial News

Eagle Genomics completes venture financing

...Cambridge, U.K. Business: Bioinformatics Date completed: 9/2/13 Type: Venture financing Raised: £590,000 ($917,686) Investors: Midven...
BioCentury | Jan 31, 2011
Financial News

Microvisk completes venture financing

...Venture financing Raised: £6 million ($9.6 million) Investors: Porton Capital; Oxford Technology Management; New Hill; Midven...
BioCentury | Sep 20, 2010
Financial News

Microvisk completes venture financing

...Venture financing Raised: £2.5 million ($3.9 million) Investors: Oxford Technology Management; Porton Capital; New Hill; Midven...
Items per page:
1 - 4 of 4